Latest Breaking News On - Scientific presentations - Page 4 : comparemela.com

Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia

Additional data from recently reported positive Phase 3 RESILIENT trial will be presentedCHATHAM, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman, M.D., Chief Executive Officer, will present at The 6th International Congress on Controversies in Fibromyalgia in Brussels, Belgium on March 7, 2024. The pres

Bruxelles capitaleBen shannonSeth ledermanJessica morrisPeter vozzoZembrace symtouchTonix pharmaceuticalsExchange commissionDrug administrationTonix pharmaceuticals holding corpInternational congress on controversies in fibromyalgiaPharmaceuticals holdingChief executive officerInternational congressScientific presentationsNew drug application

4DMT to Host Corporate Webcast to Discuss Interim Data from Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 in Wet AMD Patients with Severe Disease Activity & High Treatment Burden

Initial interim landmark data analysis will be presented by Arshad M. Khanani, M.D., M.A., FASRS, Principal Investigator of the PRISM clinical trial at Angiogenesis, Exudation, and Degeneration 2024.

United statesKatherine smithJulian peiArshadm khananiReno school of medicineClinical associate professor at university of nevadaClinical research at sierra eye associatesClinical data programCorporate communicationsPrincipal investigatorMolecular therapeuticsWebcast detailsTreatment burdenInterim clinical dataDegeneration presentation detailsInterim results

4DMT to Present Interim 24 Week Data from Randomized Phase 2 PRISM Clinical Trial of 4D-150 in High Treatment Need Wet AMD Patients at Angiogenesis, Exudation, and Degeneration 2024 Conference

Initial interim landmark data analysis to be presented by Arshad M. Khanani, M.D., M.A., FASRS, Principal Investigator of the PRISM clinical trial, on Saturday, February 3, 2024 at 4:20 p.m. ET .

United statesKatherine smithArshadm khananiJulian peiReno school of medicineClinical associate professor at university of nevadaCorporate communicationsClinical research at sierra eye associatesPrincipal investigatorMolecular therapeuticsDose expansionDegeneration presentation detailsInterim resultsRandomized phaseExpansion stageHigh need patients

4DMT to Present Interim 24 Week Data from Randomized Phase 2 PRISM Clinical Trial of 4D-150 in High Treatment Need Wet AMD Patients at Angiogenesis, Exudation, and Degeneration 2024 Conference

4DMT to Present Interim 24 Week Data from Randomized Phase 2 PRISM Clinical Trial of 4D-150 in High Treatment Need Wet AMD Patients at Angiogenesis, Exudation, and Degeneration 2024 Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesArshadm khananiKatherine smithJulian peiCorporate communicationsClinical associate professor at university of nevadaClinical research at sierra eye associatesReno school of medicinePresent interimRandomized phaseHigh treatment need wetPrincipal investigatorMolecular therapeuticsDose expansionDegeneration presentation detailsInterim results

Tonix Pharmaceuticals Announces New Data Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) in Heart Xenotransplantation in Animal Models at the ACS Clinical Congress and IPITA-IXA-CTRMS Joint Congress

30.10.2023 - Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital TNX-1500 is currently in Phase 1 Clinical Development Tonix is Developing TNX-1500 for Prevention of Kidney Allograft Rejection as the First . Seite 1

United statesSeth ledermanIkechukwu ilekaClinical congressTonix pharmaceuticalsInternational xenotransplantation associationTransplantation sciencesRegenerative medicine societyInternational pancreasTonix pharmaceuticals holding corpIslet transplant associationAmerican college of surgeonsPharmaceuticals holdingAmerican collegeCell transplantJoint congress